FDA Warning Letter — Genetrace
The FDA took a Warning Letter action against Genetrace on Jan 8, 2026 (Bethesda, MD). The action was issued by CBER and concerns biologics products.
Action details
- Facility
- Genetrace
- Date
- Jan 8, 2026
- Fiscal Year
- 2026
- Product Type
- Biologics
- Center
- CBER
- Location
- Bethesda, MD (United States)